-
2 weeks ago | 
cgtlive.com | Shahzad Raza |Noah Stansfield
This is the second part of an interview with Shahzad Raza, MD. For the first part, click here. “This is very different than continuing to bring patients to the clinic every week do therapy. A treatment holiday—freedom from more treatments —at least for our timeline, I think would be an important point for these patients.
-
3 weeks ago | 
cgtlive.com | Shahzad Raza |Noah Stansfield
“So far, the data is quite promising to share that this is very safe... I'm hoping that by the next 6 months, we will have much more mature data, more patients enrolled... The phase 1b and phase 2a is quite exciting. This data does show it's a safe drug and can be given safely to the patients.”Relapsed/refractory (r/r) light chain (AL) amyloidosis remains a particularly difficult disease to treat, and as such great unmet need exists for patients in this population.
-
1 month ago | 
nature.com | Oren Pasvolsky |Lei Feng |James Davis |Aimaz Afrough |Mariola Vazquez-Martinez |Utkarsh Goel | +22 more
AbstractTeclistamab, a BCMA-directed bispecific antibody, received regulatory approval for relapsed/refractory multiple myeloma (RRMM) based on the MajesTEC-1 study. Despite the fact that myeloma is primarily a cancer of elderly adults, only 15% of MajesTEC-1 participants (n = 24) were ≥75 years old. In this multicenter retrospective study, we report real-world outcomes of a large cohort of older RRMM patients treated with teclistamab.
-
Dec 4, 2024 | 
nature.com | Maximilian Merz |Danai Dima |Nausheen Ahmed |Friedrich Stölzel |Fabian Müller |Aina Oliver-Caldes | +12 more
AbstractDespite the astonishing outcomes after chimeric antigen receptor (CAR) T-cell therapy for relapsed refractory multiple myeloma (RRMM), most patients eventually relapse. There are only limited data available on salvage therapies following relapse after BCMA-directed CAR T-cell therapy.
-
Dec 4, 2024 | nature.com | Maximilian Merz |Danai Dima |Nausheen Ahmed |Friedrich Stölzel |Fabian Müller |Aina Oliver-Caldes | +12 more
AbstractDespite the astonishing outcomes after chimeric antigen receptor (CAR) T-cell therapy for relapsed refractory multiple myeloma (RRMM), most patients eventually relapse. There are only limited data available on salvage therapies following relapse after BCMA-directed CAR T-cell therapy.
-
Nov 29, 2024 | 
medium.com | Shahzad Raza
Shahzad Raza·Follow3 min read·--In today’s digital environment, social media effect on mental health is a subject of increasing concern. Our daily use platforms like Facebook, Instagram, YouTube, and Twitter, etc, what health effect they give us? Let’s find our positive and negative advantages of them. Positive Side of Social Media1. Staying Connected:No matter how far away we are from our friends and family social media helps them stay in touch.
-
Aug 23, 2024 | 
mdpi.com | Barry Paul |Faiz Anwer |Shahzad Raza |Aytaj Mammadzadeh
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jul 13, 2024 | 
paidforarticles.com | Shahzad Raza
Owning a pool comes with the joy of relaxation and pastime, but it also requires diligent upkeep to ensure its sturdiness and protection. One essential factor of pool protection that is frequently ignored is timely pool tile repair. Pool tiles not only enhance the aesthetic appeal of your pool but additionally serve functional purposes including waterproofing and stopping water harm to the pool structure.
-
May 30, 2024 | 
nature.com | Danai Dima |James Davis |Hussein Awada |Faiz Anwer |Shahzad Raza |Zahra Mahmoudjafari | +2 more
AbstractThe presence of extramedullary disease (EMD) has been associated with poor outcomes in patients with relapsed-refractory multiple myeloma (RRMM). Herein, we report the outcomes of RRMM patients who were treated with standard-of-care (SOC) chimeric antigen receptor (CAR) T-cell therapy and had active extraosseous EMD before the infusion. Data were retrospectively collected from patients at three US institutions with the intent to receive SOC CAR T.
-
Apr 25, 2024 | 
indibloghub.com | Shahzad Raza
Your Mazda is something other than a method of transportation; a believed friend gets you where you really want to go dependably and proficiently. To guarantee your Mazda stays out and about long into the future, standard support and fix are fundamental. By following a few straightforward tips and remaining proactive with your vehicle care, you can broaden the life expectancy of your Mazda and appreciate many effortless miles.
